(redirected from Age-related macular degeneration)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.
Related to Age-related macular degeneration: glaucoma, diabetic retinopathy
ARMDAge-Related Macular Degeneration (eye disease)
ARMDAtapi Removable Media Device
ARMDAeronautics Research Mission Directorate (NASA)
ARMDAge-Related Macular Disease (eye disease)
ARMDAutosomal Recessive Muscular Dystrophy
ARMDATAPI Removable Drive
References in periodicals archive ?
Elevated C-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration.
Studies of early age-related macular degeneration have shown that lutein, zeaxanthin, and meso-zeaxanthin increase macular pigment optical density with continued supplementation (generally one or more years).
Geographically, North America dominated the global market of age-related macular degeneration in 2015; whereas, the Asia-Pacific market is expected to witness the fastest growth, during the forecast period.
The report provides an analysis of age-related macular degeneration partnering deals.
From there, clinical trials will be designed to test potential benefit in patients with later-stage age-related macular degeneration.
These data appear to be the strongest evidence to date to support" eating fatty acids, such as those found in fish, for the primary prevention of age-related macular degeneration and might lead to a reduction in the number of people diagnosed with the condition, the study's authors said.
A second study found that running appeared to reduce the risk of age-related macular degeneration.
Another study report, "Dietary Intake of Antioxidants and Risk of Age-Related Macular Degeneration," was published in the Journal of the American Medical Association (December 28, 2005).
Immunological factors in the pathogenesis and treatment of age-related macular degeneration.
Murat Kalayoglu and his colleagues at the Massachusetts Eye and Ear Infirmary at Harvard Medical School, Boston, detected Chlamydia pneumoniae in the ocular tissue of five of nine patients with neovascular age-related macular degeneration (AMD) but in none of 20 people who did not have macular degeneration (Graefes.
FDA Approves New Drug Treatment for Age-Related Macular Degeneration.
Possible benefits include skin protection and reduced risk of cancer, cataracts and age-related macular degeneration.